Status:
COMPLETED
Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment
Lead Sponsor:
Campus Bio-Medico University
Collaborating Sponsors:
University of Genova
University of Padova
Conditions:
Vernal Keratoconjunctivitis
Eligibility:
All Genders
5-16 years
Phase:
PHASE2
PHASE3
Brief Summary
This interventional study aims to evaluate the efficacy of oral administration of Lactobacillus Rhamnosus GG in preventing relapses of ocular inflammation in Vernal Keratoconjunctivitis (VKC) patients...
Detailed Description
Vernal keratoconjunctivitis (VKC) is a chronic allergic disease, characterised by ocular surface inflammation lasting all year with seasonal relapses. Active phases of VKC are characterised by intense...
Eligibility Criteria
Inclusion
- Diagnosis of VKC performed on the basis of personal and family history of systemic allergic diseases, clinical examination (presence of conjunctival tarsal and/or limbal papillae) and presence of eosinophils in the conjunctival scraping.
Exclusion
- Contact lens wearers,
- Patients affected by other ocular diseases,
- Patients subjected to ocular surgery in the preceding 6 months,
- Patients under eye drop or systemic treatments for other diseases,
- Patients enrolled in experimental trials in the preceding 6 months.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2009
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00445120
Start Date
March 1 2007
End Date
January 1 2009
Last Update
January 29 2009
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Genova
Genova, Italy
2
University of Padua
Padua, Italy
3
University Campus Bio-Medico
Rome, Italy, 00155